Volume 4, Issue 8, Page 2 (August 2009)
4 of 44
PREVIEW
FULL TEXT
FULL-TEXT PDF (110 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The Food and Drug Administration approved a supplemental indication for teriparatide to treat glucocorticoid-induced osteoporosis in adults at high fracture risk.
PII: S1558-0164(09)70222-6
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.